<DOC>
	<DOCNO>NCT01531114</DOCNO>
	<brief_summary>Dual antiplatelet therapy essential patient follow ST-Elevation myocardial infarction ( STEMI ) percutaneous coronary intervention ( PCI ) drug elute stent implantation . Current guideline recommend prasugrel ticagrelor patient STEMI undergo primary PPCI . We seek investigate superiority antiplatelet effect term PR level load dose ( LD ) Prasugrel ( 60 mg ) versus LD Ticagrelor ( 180 mg ) diabetic patient STEMI undergo primary PCI 1 2 hour post drug administration . Secondary end-points : PR level measure 6 12 hour post study drug administrationin hospital . All consecutive diabetic patient STEMI undergo PPCI stent implantation consider PR assessment 1-2-6-12 h drug LD administration . All patient must naïve platelet P2Y12 receptor inhibition therapy . A subanalysis perform two study group accord insulin treatment .</brief_summary>
	<brief_title>PraSugrel v TicagrElor ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Diabetic patient acute coronary syndrome patient underwent primary PCI naïve platelet P2Y12 receptor inhibition therapy history bleed diathesis chronic oral anticoagulation treatment contraindication antiplatelet therapy PCI coronary artery bypass grafting ( CABG ) &lt; 3 month hemodynamic instability platelet count &lt; 100,000/μl hematocrit &lt; 30 % creatinine clearance &lt; 25 ml/min Patients history stroke contraindication prasugrel administration patient weigh &lt; 60 kg patient treat morphine &gt; 75 year age .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Diabetes mellitus</keyword>
	<keyword>antiplatelet effect</keyword>
	<keyword>prasugrel</keyword>
	<keyword>ticagrelor</keyword>
	<keyword>STEMI</keyword>
	<keyword>Insulin</keyword>
</DOC>